<DOC>
	<DOCNO>NCT02146391</DOCNO>
	<brief_summary>This study open-label , randomize , single-center , single-dose , two-way crossover study PK property Androxal healthy male subject . Twelve male subject receive single dose Androxal 25 mg feed fast state .</brief_summary>
	<brief_title>Study Evaluate Effect Food Upon Pharmacokinetics Androxal</brief_title>
	<detailed_description />
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<criteria>1 . Speak , read , understand English Spanish willing able provide write informed consent IRBapproved form prior initiation study procedure ; 2 . Male ; age 1860 BMI 2542 kg/m2 inclusive 3 . No significant abnormal finding screen physical examination evaluate Investigator ; 4 . Normal laboratory value ( abnormal clinically significant ) screening determined Investigator ; 5 . Subject willing remain clinic screen visit 2 overnight treatment visit ( approximately 36 hour treatment visit ) 6 . Must able swallow gelatin capsule ; 7 . Must willing remain clinic treatment visit 1 . Known hypersensitivity Clomid ; 2 . Abnormal screen visit vital sign clinical laboratory evaluation consider clinically significant Investigator ; 3 . A hematocrit &gt; 54 % hemoglobin &gt; 17 g/dL . 4 . Subject significant organ abnormality disease determine Investigator ; 5 . Any medical condition would interfere study determined Investigator ; 6 . Participation clinical trial investigational medication within 30 day prior study medication administration ; 7 . An acute illness within 5 day study medication administration ; 8 . Positive urine drug screen screen visit ; 9 . Known history HIV and/or Hepatitis B C 10 . Tobacco ( nicotine product ) use 3 month prior study ; 11 . A mental condition render subject unable understand nature , scope , possible consequence study and/or evidence uncooperative attitude , determine Investigator ; 12 . History venous thromboembolic disease ( e.g . deep vein thrombosis pulmonary embolism ) ; 13 . History myocardial infarction , unstable angina , symptomatic heart failure , ventricular dysrhythmia , know history QTc interval prolongation ; 14 . An employee family member employee study site Sponsor ; 15 . Previous participation clinical study Androxal .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>